These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15928327)

  • 1. Co-accumulation of dendritic cells and natural killer T cells within rupture-prone regions in human atherosclerotic plaques.
    Bobryshev YV; Lord RS
    J Histochem Cytochem; 2005 Jun; 53(6):781-5. PubMed ID: 15928327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrastructural evidence for association of vascular dendritic cells with T-lymphocytes and with B-cells in human atherosclerosis.
    Bobryshev YV; Watanabe T
    J Submicrosc Cytol Pathol; 1997 Apr; 29(2):209-21. PubMed ID: 9165715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular dendritic cells and atherosclerosis.
    Bobryshev YV; Lord RS; Rainer S; Jamal OS; Munro VF
    Pathol Res Pract; 1996 May; 192(5):462-7. PubMed ID: 8832751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased infiltration of CD1d and natural killer T cells in periodontal disease tissues.
    Amanuma R; Nakajima T; Yoshie H; Yamazaki K
    J Periodontal Res; 2006 Feb; 41(1):73-9. PubMed ID: 16409258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of vascular dendritic cells in human atherosclerotic carotid plaques.
    Kawahara I; Kitagawa N; Tsutsumi K; Nagata I; Hayashi T; Koji T
    Hum Pathol; 2007 Sep; 38(9):1378-85. PubMed ID: 17555794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CpG ODN enhance antigen-specific NKT cell activation via plasmacytoid dendritic cells.
    Marschner A; Rothenfusser S; Hornung V; Prell D; Krug A; Kerkmann M; Wellisch D; Poeck H; Greinacher A; Giese T; Endres S; Hartmann G
    Eur J Immunol; 2005 Aug; 35(8):2347-57. PubMed ID: 16025562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innate Valpha14(+) natural killer T cells mature dendritic cells, leading to strong adaptive immunity.
    Fujii S; Shimizu K; Hemmi H; Steinman RM
    Immunol Rev; 2007 Dec; 220():183-98. PubMed ID: 17979847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VCAM-1 expression and network of VCAM-1 positive vascular dendritic cells in advanced atherosclerotic lesions of carotid arteries and aortas.
    Bobryshev YV; Lord RS; Rainer SP; Munro VF
    Acta Histochem; 1996 Apr; 98(2):185-94. PubMed ID: 8739303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of the CD1d-natural killer T cell pathway in neointima formation after vascular injury.
    Ström A; Wigren M; Hultgårdh-Nilsson A; Saxena A; Gomez MF; Cardell S; Fredrikson GN; Nilsson J
    Circ Res; 2007 Oct; 101(8):e83-9. PubMed ID: 17885216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular profiling reveals distinct functional attributes of CD1d-restricted natural killer (NK) T cell subsets.
    Rolf J; Berntman E; Stenström M; Smith EM; Månsson R; Stenstad H; Yamagata T; Agace W; Sigvardsson M; Cardell SL
    Mol Immunol; 2008 May; 45(9):2607-20. PubMed ID: 18304639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High levels of myeloid-related protein 14 in human atherosclerotic plaques correlate with the characteristics of rupture-prone lesions.
    Ionita MG; Vink A; Dijke IE; Laman JD; Peeters W; van der Kraak PH; Moll FL; de Vries JP; Pasterkamp G; de Kleijn DP
    Arterioscler Thromb Vasc Biol; 2009 Aug; 29(8):1220-7. PubMed ID: 19520974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S-100 positive cells in human arterial intima and in atherosclerotic lesions.
    Bobryshev YV; Lord RS
    Cardiovasc Res; 1995 May; 29(5):689-96. PubMed ID: 7606759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional profile of activated dendritic cells in unstable atherosclerotic plaque.
    Erbel C; Sato K; Meyer FB; Kopecky SL; Frye RL; Goronzy JJ; Weyand CM
    Basic Res Cardiol; 2007 Mar; 102(2):123-32. PubMed ID: 17136419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The natural killer T lymphocyte: a player in the complex regulation of autoimmune diabetes in non-obese diabetic mice.
    Cardell SL
    Clin Exp Immunol; 2006 Feb; 143(2):194-202. PubMed ID: 16412042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of CD1d-restricted NK T lymphocytes in the immune response to oral infection with Salmonella typhimurium.
    Berntman E; Rolf J; Johansson C; Anderson P; Cardell SL
    Eur J Immunol; 2005 Jul; 35(7):2100-9. PubMed ID: 15940666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NKT cells: T lymphocytes with innate effector functions.
    Van Kaer L
    Curr Opin Immunol; 2007 Jun; 19(3):354-64. PubMed ID: 17428648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques.
    Yilmaz A; Lochno M; Traeg F; Cicha I; Reiss C; Stumpf C; Raaz D; Anger T; Amann K; Probst T; Ludwig J; Daniel WG; Garlichs CD
    Atherosclerosis; 2004 Sep; 176(1):101-10. PubMed ID: 15306181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H2-D(d)-mediated upregulation of interleukin-4 production by natural killer T-cell and dendritic cell interaction.
    Mizuuchi K; Yanagawa Y; Iwabuchi K; Namba K; Kitaichi N; Ohno S; Onoé K
    Immunology; 2008 May; 124(1):102-11. PubMed ID: 18194275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for natural killer T cells and CD1d molecules in counteracting suppression of hematopoiesis in mice induced by infection with murine cytomegalovirus.
    Broxmeyer HE; Dent A; Cooper S; Hangoc G; Wang ZY; Du W; Gervay-Haque J; Sriram V; Renukaradhya GJ; Brutkiewicz RR
    Exp Hematol; 2007 Apr; 35(4 Suppl 1):87-93. PubMed ID: 17379092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between B-lymphocytes and type 1 NKT cells in autoimmune diabetes.
    Dufour FD; Silveira PA; Baxter AG
    J Immunotoxicol; 2008 Apr; 5(2):249-57. PubMed ID: 18569396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.